Cost-effectiveness of bypass surgery versus stenting in patients with multivessel coronary artery disease

American Journal of Medicine

Volumn 115, Issue 5, 2003, Pages 382-389

  Yock, Cynthia A ^a   Boothroyd, Derek B ^a   Owens, Douglas K ^a,b   Garber, Alan M ^a,b   Hlatky, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY CATHETER; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUALITY OF LIFE; RESTENOSIS; SAFETY; THEORETICAL MODEL; TREATMENT OUTCOME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; COST; DECISION TREE; ECONOMICS; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DECISION TREES; HUMANS; MARKOV CHAINS; QUALITY-ADJUSTED LIFE YEARS; STENTS; TREATMENT OUTCOME;

EID: 0142150035     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00296-1     Document Type: Article

References (54)

1. Weintraub W.S., Craver J.M., Jones E.L., et al. Improving cost and outcome of coronary surgery. Circulation. 98:(19 suppl):1998;1123-1128.
2. Ferguson T.B.J., Hammill B.G., Peterson E.D., et al. A decade of change - risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999 a report from the STS National Database Committee and the Duke Clinical Research Institute . Ann Thorac Surg. 73:2002;480-489.
3. Puskas J.D., Thourani V.H., Marshall J., et al. Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients. Ann Thorac Surg. 71:2001;1477-1484.
4. Cameron A., David K.B., Green G., et al. Coronary bypass surgery with internal-thoracic-artery grafts effects on survival over a 15-year period . N Engl J Med. 334:1996;216-219.
5. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 335:1996;217-225.
6. Weintraub W.S., Mahoney E.M., Ghazzal Z.M., et al. Trends in outcome and costs of coronary intervention in the 1990's. Am J Cardiol. 88:2001;497-503.
7. Seshadri N., Whitlow P.L., Acharya N., et al. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 106:2002;2346-2350.
8. Califf R.M. Restenosis the cost to society . Am Heart J. 130:1995;680-684.
9. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Investigators. N Engl J Med. 331:1994;496-501.
10. Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
11. Babapulle M.N., Eisenberg M.J. Coated stents for the prevention of restenosis part II . Circulation. 106:2002;2859-2866.
12. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesion) trial. Circulation. 106:2002;798-803.
13. Weintraub W.S., Mauldin P.D., Becker E., et al. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation. 92:1995;2831-2840.
14. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 35:2000;1122-1129.
15. Feit F., Brooks M.M., Sopko G., et al. Long-term clinical outcome in the bypass angioplasty revascularization investigation registry. Comparison with the randomized trial. Circulation. 101:2000;2795-2802.
16. King S.B. III, Kosinski A.S., Guyton R.A., Lembo N.J., Weintraub W.S. Eight-year mortality in the Emory Angioplasty Versus Surgery Trial (EAST). J Am Coll Cardiol. 35:2000;1116-1121.
17. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 344:2001;1117-1124.
18. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial) a randomised controlled trial . Lancet. 360:2002;965-970.
19. Anderson H.V., Shaw R.E., Brindis R.G., et al. A contemporary overview of percutaneous coronary interventions. J Am Coll Cardiol. 39:2002;1096-1103.
20. Holmes D.R., Gersh B.J. And the answer is, it doesn't much matter. Circulation. 106:2002;11-13.
21. Bhatt D.L., Topol E.J. Debate PCI or CABG for multivessel disease? Viewpoint: no clear winner in an unfair fight . Curr Control Trials Cardiovasc Med. 2:2001;260-262.
22. Bourassa M.G., Roubin G.S., Detre K.M., et al. Bypass Angioplasty Revascularization Investigation patient screening, selection and recruitment . Am J Cardiol. 75:1995;3C-8C.
23. Yock C.A., Boothroyd D.B., Owens D.K., Winston C., Hlatky M.A. Projected long-term costs of coronary stenting in multivessel coronary disease based on the experience of the Bypass Angioplasty Revascularization Investigation (BARI). Am Heart J. 140:2000;556-564.
24. Hlatky M.A., Boothroyd D.B., Brooks M.M., et al. Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. Am Heart J. 138:(2 pt 1):1999;376-383.
25. Hlatky M.A., Rogers W.J., Johnstone I., et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med. 336:1997;92-99.
26. Hlatky M.A., Boothroyd D.B., Johnstone I.M. Economic evaluation in long-term clinical trials. Stat Med. 21:2002;2879-2888.
27. Melsop K.A., Boothroyd D.B., Hlatky M.A. Quality of life and time trade-off utility measures in patients with coronary artery disease. Am Heart J. 145:2003;36-41.
28. Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C. Cost-Effectiveness in Health and Medicine. 1996;425 Oxford University Press, New York.
29. Mathew V., Garratt K., Holmes D.J. Clinical outcome after multivessel coronary stent implantation. Am Heart J. 138:1999;1105-1110.
30. Antoniucci D., Valenti R., Santoro G.M., et al. Restenosis after coronary stenting in clinical practice. Am Heart J. 135:1998;510-518.
31. Rodriguez A., Bernardi V., Navia J., et al. Argentine Randomized Study coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results . J Am Coll Cardiol. 37:2001;51-58.
32. George C.J., Baim D.S., Brinker J.A., et al. One-year follow-up of the stent restenosis (STRESS I) study. Am J Cardiol. 81:1998;860-865.
33. Macaya C., Serruys P.W., Ruygrok P., et al. Continued benefit of coronary stenting versus balloon angioplasty one-year clinical follow-up of Benestent Trial . J Am Coll Cardiol. 27:1996;255-261.
34. Sukin C.A., Baim D.S., Caputo R.P., et al. The impact of optimal stenting techniques on cardiac catheterization laboratory resource utilization and costs. Am J Cardiol. 79:1997;275-280.
35. Price survey. Stent prices expected to decline. Hosp Mater Manage. 2001;26:12-13.
36. Weintraub W.S., Becker E.R., Mauldin P.D., et al. Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty Versus Surgery Trials (EAST). Am J Cardiol. 86:2000;747-752.
37. Nease R.F. Jr, Kneeland T., O'Connor G.T., et al. Variation in patient utilities for outcomes of the management of chronic stable angina. JAMA. 273:1995;1185-1190.
38. Fryback D.G., Lawrence W.F. Dollars may not buy as many QALYs as we think a problem with defining quality-of-life adjustments . Med Decis Making. 17:1997;276-284.
39. Fryback D.G., Dasbach E.J., Klein R.R., et al. The Beaver Dam Health Outcomes Study initial catalog of health-state quality factors . Med Decis Making. 13:1993;89-102.
40. Tengs T.O., Wallace A. One thousand health related quality of life estimates. Med Care. 38:2000;583-637.
41. Cohen D.J., Breall J.A., Kalon K.L., et al. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model. Circulation. 89:1994;1859-1874.
42. Gibson C.M., Kuntz R.E., Nobuyoshi M., Rosner B., Baim D.S. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of a lesion-based restenosis analysis. Circulation. 87:1993;1123-1129.
43. Myers W.O., Blackstone E.H., Davis K., Foster E.D., Kaiser G.C. CASS registry. Long-term surgical survival. J Am Coll Cardiol. 33:1999;488-498.
44. Cantor W.J., Peterson E.D., Popma J.J., et al. Provisional stenting strategies systematic overview and implications for clinical decision-making . J Am Coll Cardiol. 36:2000;1142-1151.
45. LeFeuvre C., Bonan R., Cote G., et al. Five- to ten-year outcome after multivessel percutaneous transluminal coronary angioplasty. Am J Cardiol. 71:1993;1153-1158.
46. Chen L.C., Chen Y.H., Chan W.L., et al. Clinical and angiographic determinants of adverse cardiac events in patients with stent restenosis. Catheter Cardiovasc Interv. 55:2002;331-337.
47. Newman M.F., Kirchner J.L., Phillips-Bute B., et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 344:2001;395-402.
48. Hlatky M.A., Bacon C., Boothroyd D., et al. Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. Circulation. 96:(9 suppl):1997;II11-II14.
49. Van Dijk D., Jansen E.W., Hijman R., et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery a randomized trial . JAMA. 287:2002;405-412.
50. Garber A.M. Advances in cost-effectiveness analysis of health interventions. Culyer A.J., Newhouse J.P. Handbook of Health Economics. Vol 1:2000;182-221 Elsevier Science, Amsterdam.
51. Weintraub W.S., Thompson T.D., Culler S., et al. Targeting patients undergoing angioplasty for thrombus inhibition. A cost-effectiveness and decision support model. Circulation. 102:2000;392-398.
52. Kimmel S.E., Localio A.R., Krone R.J., et al. The effects of contemporary use of coronary stents on in-hospital mortality. J Am Coll Cardiol. 37:2001;499-504.
53. Cohen E.A., Young W., Slaughter P.A., et al. Trends in clinical and economic outcomes of coronary angioplasty from 1992 to 1995 a population-based analysis . Am Heart J. 137:1999;1012-1018.
54. Williams D.O., Holubkov R., Yeh W., et al. Percutaneous coronary intervention in the current era compared with 1985-1986. The National Heart, Lung, and Blood Institute Registries. Circulation. 102:2000;2945-2951.